Heeney J, Bogers W, Buijs L, Dubbes R, ten Haaft P, Koornstra W, Niphuis H, Nara P, Teeuwsen V
Department of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands.
Immunol Lett. 1996 Jun;51(1-2):45-52. doi: 10.1016/0165-2478(96)02554-0.
HIV-1 infected chimpanzees are relatively resistant to the development of AIDS despite their close genetic relatedness to humans and their susceptibility to HIV-1 infection. We have systematically studied possible reasons for their relative ability to maintain T helper (Th) cell numbers and immune competence in the presence of chronic HIV-1 infection. Factors which may alone or together cause the loss in T-cell dependent immunity include: (i) the loss of Th cell function; (ii) the loss of Th cells; and (iii) the loss of capacity for Th cell renewal. Differences in the in vivo and in vitro responses of T lymphocytes from chimpanzees and humans were compared for evidence of HIV-1 related T-cell dysfunction. In contrast to HIV infected individuals, HIV-1 infected chimpanzees maintained strong Th cell proliferative and cytokine responses after receiving tetanus toxoid boosts. In addition there was no abnormal Th1 to Th2 shift as is suggested to occur in AIDS patients. There was no evidence of Th cell dysfunction such as increased level of programmed cell death (PCD) or immune activation in HIV-1 infected chimpanzees in contrast to HIV-1 infected asymptomatic humans. Anergy could be induced with HIV-1 gp120 in human but not chimpanzee Th lymphocytes. We then asked if there was a direct loss of chimpanzee CD4+ cells due to HIV-1 infection in vitro. Infection of chimpanzee CD4+ lymphocyte cultures with HIV-1 in the absence of CD8+ cells resulted in marked cytopathic effect with complete lysis and loss of cells within 3 weeks. We concluded that most chronic HIV-1 infected chimpanzees were able to maintain relatively stable CD4+ lymphocyte numbers despite CD4+ lymphocyte destruction due to direct effects of the virus. Furthermore, there was no evidence of indirect Th cell loss, since neither increased levels of anergy nor apoptosis were observed. Lymph node biopsies from HIV-1 infected chimpanzees revealed that MHC class II rich regions of lymph nodes remained intact, in contrast to the involution of these regions in infected humans. This suggested that chimpanzees may maintain the capacity for Th cell renewal by preserving this MHC class II lymphoid environment. The data presented in this paper suggests that chimpanzees may preserve this critical MHC class II-Th cell environment by dramatically suppressing extra-cellular virus load and that this may be in part mediated by soluble lentivirus suppressing factors.
尽管与人类有密切的遗传关系且易感染HIV-1,但感染HIV-1的黑猩猩对艾滋病的发展相对具有抵抗力。我们系统地研究了它们在慢性HIV-1感染情况下维持辅助性T(Th)细胞数量和免疫能力的相对能力的可能原因。单独或共同导致T细胞依赖性免疫丧失的因素包括:(i)Th细胞功能丧失;(ii)Th细胞丧失;以及(iii)Th细胞更新能力丧失。比较了黑猩猩和人类T淋巴细胞在体内和体外反应的差异,以寻找与HIV-1相关的T细胞功能障碍的证据。与HIV感染个体不同,感染HIV-1的黑猩猩在接受破伤风类毒素加强免疫后维持了强烈的Th细胞增殖和细胞因子反应。此外,没有出现如艾滋病患者中所提示的Th1向Th2的异常转变。与感染HIV-1的无症状人类不同,在感染HIV-1的黑猩猩中没有Th细胞功能障碍的证据,如程序性细胞死亡(PCD)水平升高或免疫激活。HIV-1 gp120可诱导人类Th淋巴细胞无反应性,但不能诱导黑猩猩Th淋巴细胞无反应性。然后我们询问在体外HIV-1感染是否会直接导致黑猩猩CD4+细胞的丧失。在没有CD8+细胞的情况下,用HIV-1感染黑猩猩CD4+淋巴细胞培养物会导致明显的细胞病变效应,在三周内细胞完全裂解并丧失。我们得出结论,尽管病毒的直接作用导致CD4+淋巴细胞破坏,但大多数慢性HIV-1感染的黑猩猩能够维持相对稳定的CD4+淋巴细胞数量。此外,没有间接Th细胞丧失的证据,因为未观察到无反应性或凋亡水平升高。来自感染HIV-1的黑猩猩的淋巴结活检显示,淋巴结中富含MHC II类分子的区域保持完整,这与感染人类中这些区域的退化形成对比。这表明黑猩猩可能通过保留这种MHC II类淋巴环境来维持Th细胞更新能力。本文所呈现的数据表明,黑猩猩可能通过显著抑制细胞外病毒载量来保留这种关键的MHC II类-Th细胞环境,并且这可能部分由可溶性慢病毒抑制因子介导。